Shefali Agarwal - Net Worth and Insider Trading
Shefali Agarwal Net Worth
The estimated net worth of Shefali Agarwal is at least $236,878 dollars as of 2024-06-07. Shefali Agarwal is the See Remarks of Epizyme Inc and owns about 156,385 shares of Epizyme Inc (EPZM) stock worth over $229,886. Shefali Agarwal is also the Director of Fate Therapeutics Inc and owns about 1,840 shares of Fate Therapeutics Inc (FATE) stock worth over $6,992. Details can be seen in Shefali Agarwal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shefali Agarwal has not made any transactions after 2022-06-07 and currently still holds the listed stock(s).
Transaction Summary of Shefali Agarwal
Shefali Agarwal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shefali Agarwal owns 3 companies in total, including Epizyme Inc (EPZM) , Fate Therapeutics Inc (FATE) , and Gritstone Bio Inc (GRTS) .
Click here to see the complete history of Shefali Agarwal’s form 4 insider trades.
Insider Ownership Summary of Shefali Agarwal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EPZM | Epizyme Inc | 2022-02-07 | Chief Medical Officer |
| FATE | Fate Therapeutics Inc | 2022-06-07 | director |
| GRTS | Gritstone Bio Inc | 2023-06-16 | director |
Shefali Agarwal Latest Holdings Summary
Shefali Agarwal currently owns a total of 2 stocks. Among these stocks, Shefali Agarwal owns 156,385 shares of Epizyme Inc (EPZM) as of February 7, 2022, with a value of $229,886 and a weighting of 97.05%. Shefali Agarwal also owns 1,840 shares of Fate Therapeutics Inc (FATE) as of June 7, 2022, with a value of $6,992 and a weighting of 2.95%.
Latest Holdings of Shefali Agarwal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EPZM | Epizyme Inc | 2022-02-07 | 156,385 | 1.47 | 229,886 |
| FATE | Fate Therapeutics Inc | 2022-06-07 | 1,840 | 3.80 | 6,992 |
Holding Weightings of Shefali Agarwal
Shefali Agarwal Form 4 Trading Tracker
According to the SEC Form 4 filings, Shefali Agarwal has made a total of 11 transactions in Epizyme Inc (EPZM) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Epizyme Inc is the sale of 1,058 shares on February 7, 2022, which brought Shefali Agarwal around $1,587.
According to the SEC Form 4 filings, Shefali Agarwal has made a total of 2 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 841 shares on June 7, 2022, which brought Shefali Agarwal around $18,410.
Insider Trading History of Shefali Agarwal
- 1
Shefali Agarwal Trading Performance
Shefali Agarwal Ownership Network
Shefali Agarwal Owned Company Details
What does Epizyme Inc do?
Who are the key executives at Epizyme Inc?
Shefali Agarwal is the Chief Medical Officer of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .
Epizyme Inc (EPZM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Epizyme Inc Insider Transactions
Shefali Agarwal Mailing Address
Above is the net worth, insider trading, and ownership report for Shefali Agarwal. You might contact Shefali Agarwal via mailing address: C/o Epizyme, Inc., 400 Technology Square, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
